Exagen (XGN) Total Current Liabilities (2018 - 2026)

Exagen (XGN) has 9 years of Total Current Liabilities data on file, last reported at $12.6 million in Q1 2026.

• Quarterly Total Current Liabilities fell 10.23% year-over-year to $12.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.6 million (down 10.23% YoY) and the FY2025 annual result came in at $14.2 million, up 4.83% from the prior year.
• Total Current Liabilities retreated to $12.6 million in Q1 2026, from $14.2 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $14.2 million in Q4 2025 to a low of $8.6 million in Q2 2023.
• A 5-year average of $11.0 million and a median of $10.3 million in 2025 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2023 — Total Current Liabilities decreased 22.01% — and 2025, when it jumped 59.34%.
• Tracing XGN's Total Current Liabilities over 5 years: stood at $9.6 million in 2022, then advanced by 23.68% to $11.9 million in 2023, then increased by 13.48% to $13.5 million in 2024, then gained by 4.83% to $14.2 million in 2025, then slipped by 11.26% to $12.6 million in 2026.
• The last three Total Current Liabilities figures came in at $12.6 million (Q1 2026), $14.2 million (Q4 2025), and $12.9 million (Q3 2025), per Business Quant data.